Daniel C Baumgart, MD PhD MBA FRCP (London) AGAF

Professor and Director
Division of Gastroenterology
AHS Section Head Gastroenterology, Edmonton Zone
Director, Inflammatory Bowel Disease Unit
University of Alberta
Edmonton, Alberta

Daniel C. Baumgart, MD PhD MBA FACP FRCP (Lon) AGAF went to medical school in Berlin, Basle (Switzerland) and Würzburg (Bavaria). He received his training in internal medicine, gastroenterology, hepatology and immunology at the Charité and as a German Academic Exchange Service (DAAD) and German Research Foundation (DFG) scholar at the University of Pennsylvania, Philadelphia, PA, USA, Georgetown University, Washington, DC, USA, Lombardi Cancer Center, National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) Bethdesda, MD, USA, Inova Fairfax Hospital (Inova Medical Campus), Fairfax, VA, USA, Virginia Hospital Center (Mayo Clinic Care Network), Arlington, VA, USA as well as US Public Health Service und Veterans Affairs Medical Center in Washington, DC, USA. Dr. Baumgart holds an unrestricted license to practice medicine and surgery in the US, Canada and Germany.

Prior to his current appointment as Professor and Director, Division of Gastroenterology, Alberta Health Services (AHS) Zone Head for the Edmonton Zone, and Director of the Inflammatory Bowel Disease Unit at the University of Alberta in Edmonton, Canada he served as Professor and Deputy Chief of the Department of Gastroenterology and Hepatology at Charité Medical School of the Humboldt-University of Berlin, Director of the Inflammatory Bowel Disease Center and elected Fellow at the Berlin Institute of Health (BIH) endowed by the StiftungCharité foundation. He was Visiting Professor at Yale University, New Haven, CT and Harvard University, Boston, MA, USA.

Dr. Baumgart is actively involved in the development and evaluation of novel diagnostic and therapeutic concepts for Crohn’s disease and ulcerative colitis including new modalities of optical detection to visualize inflammation, mucosal damage and epithelial restitution and image guided intervention. He has been principal investigator in some 200 multinational clinical trials.

A trailblazer of digitization he has a strong interest in evidence based medicine, application of computers and communication technology in education, research, integration of clinical and scientific data, mathematical modeling of diseases and artificial intelligenceultimately aiming to provide precision medicine at the point of care.

His basic science laboratory is focused on the investigation of dendritic cells in innate and adaptive immunity, especially microbial recognition and human microbiome.

Dr. Baumgart has been serving on the editorial boards of leading medical and scientific journals including The Lancet, Gut and Inflammatory Bowel Diseases for more than a decade, elected member of the Cochrane IBD special interest group, elected executive board member of the German IBD Compentence Network within the German Society for Gastroenterology (DGVS) and sits on various other national and international expert, consensus and guideline panels.

A BMW Herbert Quandt Foundation responsible leadership alumnus and passionate educator, Dr. Baumgart developed an innovative integrated clinical and research training curriculum for academic physicians, that received numerous awards including the VolkswagenStiftung foundation’s Off the Beaten Track award for its extraordinary design and visionary impetus to academia and has been approved by the German Research Foundation (DFG), Federal Ministry for Education and Research (BMBF), the German Council of Science and Humanities (WR) and adopted by German medical schools nationwide.

In 2013 Dr. Baumgart was appointed fellow, American College of Physicians (FACP), Philadelphia; in 2014 fellow, American Gastroenterological Association (AGAF), Bethesda; and in 2017 Fellow of the Royal College of Physicians (FRCP), London, UK.